Measurement of Recirculation, Oxygenator Blood Volume and Cardiac Output in ECMO Using a Modified Transonic Systems (tm) HD02 Monitoring System
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Recirculation
- Sponsor
- Transonic Systems Inc.
- Enrollment
- 8
- Locations
- 1
- Primary Endpoint
- Cardiac output, recirculation or oxygenator blood volume measurements made in patients receiving extracorporeal membrane oxygenation.
- Status
- Terminated
- Last Updated
- 9 years ago
Overview
Brief Summary
This study is to test the usefulness of ultrasound dilution measurements in patients on extracorporeal membrane oxygenation. Measurements may include; efficiency of support (recirculation), amount of clotting in the oxygenator (oxygenator blood volume), and how well the heart is working (cardiac output). At the present time there are no devices available to perform these functions.
Detailed Description
At the present time there are no devices available to measure recirculation, oxygenator blood volume and cardiac output in patients on extracorporeal membrane oxygenation. The study uses an external monitor, laptop computer, clamp on flowsensors and ultrasound dilution technology to measure blood flow. Measurements are made by injecting 0.5 - 1 ml/kg of sterile isotonic saline into the patient's extracorporeal circuit. The subject will be monitored throughout the measurements. The measurements will be coordinated with the regular care of the extracorporeal circuit.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Neonatal, pediatric or adult patients receiving venoarterial or venovenous extracorporeal membrane oxygenation.
Exclusion Criteria
- •Patients not receiving venoarterial or venovenous extracorporeal membrane oxygenation.
Outcomes
Primary Outcomes
Cardiac output, recirculation or oxygenator blood volume measurements made in patients receiving extracorporeal membrane oxygenation.
Time Frame: Duration of extracorporeal membrane oxygenation